The objectives of this proposal are to study the effects of GVHD, CsA and FK506 on T cell ontogeny and to determine whether this results in aberrant T cell function causing susceptibility to autoimmunity. I. Thymic dysfunction in animals treated with CsA or FK506 as determined by Vbeta usage. The effects of CsA and FK506 on positive and negative thymic selection will be studied. Cells that have escaped selection will be analyzed for their functional capacity including their ability to cause autoimmune disease. II. Thymic dysfunction in GVHD as determined by Vbeta usage. The effects of GVHD on positive and negative selection will be explored. furthermore, we will assess whether cells have escaped selection are functional and whether they confer susceptibility to autoimmune disease. III. Immunological consequences of the treatment of GVHD with CsA and FK506. The consequence of GVHD together with CsA or FK506 treatment will be assessed for their combined effect on thymic ontogeny. IV. Influence of GVHD, CsA or FK506 on TcR-Valpha usage. The effect on TcR-Valpha usage subsequent to GVHD or the treatment with either CsA or FK506 will be studied. Whether the function of these cells are changed under these experimental conditions will be assessed.
| Holtan, Shernan G; DeFor, Todd E; Panoskaltsis-Mortari, Angela et al. (2018) Amphiregulin modifies the Minnesota Acute Graft-versus-Host Disease Risk Score: results from BMT CTN 0302/0802. Blood Adv 2:1882-1888 |
| Ortiz-Velez, Laura; Ortiz-Villalobos, Javiera; Schulman, Abby et al. (2018) Genome alterations associated with improved transformation efficiency in Lactobacillus reuteri. Microb Cell Fact 17:138 |
| Ferrara, James L M; Chaudhry, Mohammed S (2018) GVHD: biology matters. Hematology Am Soc Hematol Educ Program 2018:221-227 |
| Major-Monfried, Hannah; Renteria, Anne S; Pawarode, Attaphol et al. (2018) MAGIC biomarkers predict long-term outcomes for steroid-resistant acute GVHD. Blood 131:2846-2855 |
| Naymagon, Steven; Naymagon, Leonard; Wong, Serre-Yu et al. (2017) Acute graft-versus-host disease of the gut: considerations for the gastroenterologist. Nat Rev Gastroenterol Hepatol 14:711-726 |
| Hartwell, Matthew J; Özbek, Umut; Holler, Ernst et al. (2017) An early-biomarker algorithm predicts lethal graft-versus-host disease and survival. JCI Insight 2:e89798 |
| Stickel, N; Hanke, K; Marschner, D et al. (2017) MicroRNA-146a reduces MHC-II expression via targeting JAK/STAT signaling in dendritic cells after stem cell transplantation. Leukemia 31:2732-2741 |
| Ferrara, James Lm; Smith, Christopher M; Sheets, Julia et al. (2017) Altered homeostatic regulation of innate and adaptive immunity in lower gastrointestinal tract GVHD pathogenesis. J Clin Invest 127:2441-2451 |
| Miller, Holly K; Braun, Thomas M; Stillwell, Terri et al. (2017) Infectious Risk after Allogeneic Hematopoietic Cell Transplantation Complicated by Acute Graft-versus-Host Disease. Biol Blood Marrow Transplant 23:522-528 |
| Renteria, Anne S; Levine, John E; Ferrara, James L M (2016) Therapeutic targets and emerging treatment options in gastrointestinal acute graft-versus-host disease. Expert Opin Orphan Drugs 4:469-484 |
Showing the most recent 10 out of 231 publications
